# PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF

> **NCT03317821** · — · COMPLETED · sponsor: **Microvention-Terumo, Inc.** · enrollment: 70 (actual)

## Conditions studied

- Dural Arteriovenous Fistula

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03317821
- **Lead sponsor:** Microvention-Terumo, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-18
- **Primary completion:** 2020-03-11
- **Final completion:** 2020-03-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03317821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03317821, "PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03317821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*